Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF

BACKGROUND: Rivaroxaban, a direct oral anticoagulant (DOAC), has become available for stroke prevention in patients with non-valular atrial fibrillation (NVAF). However, little is known about its effectiveness and safety when prescribed by general practitioners in real-life settings. METHODS: GENERA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusano, Kengo, Akao, Masaharu, Tsuji, Hikari, Matsui, Kunihiko, Hiramitsu, Shinya, Hatori, Yutaka, Odakura, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529321/
https://www.ncbi.nlm.nih.gov/pubmed/28765760
http://dx.doi.org/10.1016/j.joa.2016.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529321/
https://www.ncbi.nlm.nih.gov/pubmed/28765760
http://dx.doi.org/10.1016/j.joa.2016.12.001

Ejemplares similares